Dario Trapani, Medical Oncologist at European Institute of Oncology (IEO), Researcher at Department of Oncology and Hemato-Oncology at University of Milan, shared a post on LinkedIn:
“Today we launch a conversation on what Europe urgently needs in cancer care, with Rodrigo Lastra and Javier David Benitez fuentes from RIO.
We published a policy piece that translates the Common Sense Oncology movement into the European context.
The message is simple, but uncomfortable:
Oncology has become more technologically sophisticated and pharmacologically complex than ever, yet too often it delivers marginal gains, rising toxicity, growing inequities and a widening gap between what systems fund and what patients actually need.
Europe is not immune to this paradox.
- We spend more on cancer drugs every year, while prevention remains underfunded, palliativecare coverage is uneven, psychoncology is fragile, social determinants of health are ignored, and timetoxicity and financialtoxicity are rarely measured, let alone acted upon.
- Postal code still matters more than genetic code.
- Access still depends on geography.
- And too much of our research agenda is somewhat shaped by what is ‘commercially’ appealing rather than what is ultimately clinically meaningful.
Common Sense Oncology is pro innovation.
- It is pro-patient.
- It calls for re-centering oncology on outcomes that matter: meaningful survival, quality of life, dignity, equity, shared decision-making and independent science.
- It asks us to rebalance the system, not to dismantle it.
Now the next step: Europe needs a focused conversation!
We are hearing clinicians, researchers, nurses and all medical allies, economists, patient advocates, policymakers and academic institutions and the broader set of stakeholders – who want to help build a European-based platform to implement Common Sense Oncology principles!
A space to generate independent evidence, to challenge low value care, to prioritize impact -oriented research and care, prevention and supportive and palliative care, to push regulators toward patient-relevant endpoints, to defend public-interest research, and to design policies that reflect real patient needs.
Let’s speak:
- If you believe oncology must be scientifically rigorous and ethically grounded
- If you believe value is more than drug approval speed.
- If you believe equity is not optional.
- If you believe patients are not endpoints, but people.
Then this is your invitation -> please text your ideas inbox, and let’s create a conversation on how CSO principles can shape the future of Oncology in EU, and by extent, worldwide!”
Title: Oncology with common sense: beyond biologistic and pharmacological models
Authors: Rodrigo Lastra, Patricia Iranzo, Javier-David Benítez-Fuentes, Ana Callejo, Mara Cruellas, Jacobo Gómez Ulla, Isabel Pimentel, José Luis Pérez-Gracia, Marta Ramos, Francisco Gil Moncayo, María Álvarez Alejandro, Marta Gascón, Sergio Martínez Recio, Pilar Rivero, Jorge Bartolomé, Antonio David Lázaro Sánchez, David Fernández Garay, Alicia de Luna Aguilar, Isabel Lorenzo Lorenzo, Joan Brunet, Noemi Reguart, Dario Trapani
Read the Full Article.
More posts featuring Dario Trapani on OncoDaily.